Addressing Discrimination and Mistrust Among Black Men: Phase III
26. januar 2016 oppdatert av: Laura Bogart, Boston Children's Hospital
The purpose of this research study is to test a group program aimed at improving the quality of life of HIV+ Black men who have sex with men.
The group will address ways to cope with discrimination and will help men examine mistrust that they may have about healthcare, including doctors and other healthcare providers and HIV medications.
The aim is to provide a supportive community for HIV+ Black men.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The aim of the study is to examine whether the pilot intervention can reduce mistrust and improve coping responses to discrimination among HIV positive Black men who have sex with men (MSM).
We will conduct a small randomized pilot trial to test the feasibility of evaluation methods.
All participants will attend a baseline, a first follow-up visit, and a final follow-up visit (each 3 months apart) at which they will take computer assessments.
Participants who are assigned to the intervention will attend 9 weekly intervention sessions after baseline and before the first follow-up.
Using a wait-list control design, control group participants from the first two cohorts will be offered the intervention after they complete the final follow-up visit.
Control group participants from the third cohort will be offered the intervention after they complete the first final-up visit and before they complete their final follow-up due to timing and budgetary restraints.
We will hold three consecutive groups for our small randomized control trial.
This means that we will be recruiting continuously; once we finish recruiting for the first group, we will start recruiting for the second group, and so on.
Each group has about 12 or 13 intervention and 7-11 control participants.
Studietype
Intervensjonell
Registrering (Faktiske)
64
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02215
- Fenway Health
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Mann
Beskrivelse
Inclusion Criteria:
- 18 years-old or older
- Biologically male at birth
- Currently self-identifies as male
- Self-identifies as Black or African American (mixed-race individuals will be eligible if they primarily identify as Black or African American)
- HIV-positive
- Reported having sex with men in lifetime
- Able and willing to provide informed consent
Exclusion Criteria:
- Does not meet all of the inclusion criteria (e.g., if they are unable to provide proof of their HIV-positive status)
- Unable to provide informed consent
- Reports or presents evidence of severe mental health problems that require immediate treatment (e.g., psychotic symptoms, active suicidality at time of enrollment) or diagnosed mental disorder that would limit the ability to participate (e.g., dementia)
- Reports or presents evidence of cognitive impairments that limit the ability to comprehend the informed consent or to fully participate in the various parts of the study (assessments, intervention, homework).
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention Group
Participants will attend the baseline, first follow-up, and final follow-up study visits, at which they take computer surveys.
After their baseline interview and before their first follow-up interview, participants attend the Intervention Group, which consist of 9 weekly group sessions.
Each of the weekly sessions is led by a mental health professional and a peer facilitator who uses Cognitive Behavioral Therapy techniques to work with participants in tracking their cognitions, emotions, and behaviors in response to stressful/discrimination experiences.
|
Participants attend 9 weekly group sessions.
Each of the weekly sessions is led by a mental health professional and a peer facilitator who use Cognitive Behavioral Therapy techniques to work with participants in tracking their cognitions, emotions and behaviors in response to stressful/discrimination experiences.
|
|
Ingen inngripen: Waitlist Control
Participants are not given the Intervention Group while they are enrolled in the study. Instead, they only attend the baseline, first follow-up, and final follow-up study visits, at which they take computer surveys. After they have completed the study, participants from the first two cohorts are offered the option of attending an intervention group that is identical in content to the intervention group being studied.The third cohort is offered the intervention group after they have completed the first follow-up but before they complete the final follow-up due to timing and budgetary restraints. No data is collected and no incentives are given during these intervention groups. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Coping
Tidsramme: 3 months post-baseline
|
Improved coping scores on Brief Cope, Emotional and Behavioral Coping, and Africultural Coping scales
|
3 months post-baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mistrust
Tidsramme: 3 months post-baseline
|
Reduced mistrust scores on Medical Mistrust scale
|
3 months post-baseline
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Laura M Bogart, PhD, Boston Children's Hospital
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. juli 2014
Primær fullføring (Faktiske)
1. oktober 2015
Studiet fullført (Faktiske)
1. desember 2015
Datoer for studieregistrering
Først innsendt
12. august 2014
Først innsendt som oppfylte QC-kriteriene
20. august 2014
Først lagt ut (Anslag)
22. august 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
28. januar 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
26. januar 2016
Sist bekreftet
1. januar 2016
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IRB-P00002878
- R34MH096544-03 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .